Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The ubiquitin ligase
F-box protein 45
(
FBXO45
) is critical for synaptogenesis, neuronal migration, and synaptic transmission.
FBXO45
is included in the 3q29 microdeletion region that confers a significant risk for
schizophrenia
, as shown by rare structural variant studies. Thus,
FBXO45
is considered a prominent candidate for mediating
schizophrenia
pathogenesis. Here, we investigated rare, deleterious single nucleotide variants (SNVs) as well as small insertions and deletions (INDELs) in
FBXO45
that may contribute to
schizophrenia
susceptibility. Using Sanger sequencing, we performed mutation screening in
FBXO45
exon regions in 337
schizophrenia
patients. Novel missense or nonsense variants were followed up with a genetic association study in an independent sample set of 601
schizophrenia
patients and 916 controls, a case report for assessing the clinical consequence of the mutations, a pedigree study for measuring mutation inheritance in the proband's family, bioinformatics analyses for evaluating mutation effect on protein structure and function, and mRNA expression analysis for examining mutation transcriptional influence on
FBXO45
expression. One heterozygous, novel, and rare missense mutation (R108C) was identified in a single
schizophrenia
patient and in his healthy mother. At age 20, this patient was diagnosed with paranoid schizophrenia and carried some clinical features of 3q29 deletion phenotypes, including premorbid IQ decline. With follow-up genotyping, this mutation was not found in either the
schizophrenia
group (0/601) or the healthy control group (0/916). Bioinformatics analyses predicted that R108C probably pathologically impacted the structure and function of the
FBXO45
protein. The relative expression of
FBXO45
in SCZ case with R108C mutation was relatively low when compared to 50
schizophrenia
patients and 52 healthy controls. The R108C mutation in
FBXO45
is a rare variant with a modest effect on
schizophrenia
risk that may disrupt the structure and function of the
FBXO45
protein. Our findings also suggest that
FBXO45
may be a new attractive candidate gene for
schizophrenia
.
...
PMID:Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia. 2487 30